Furthermore, Remodelin showcased its ability to attenuate proliferation, invasion, and metastasis abilities of NSCLC by inhibiting NAT10 through the EMT pathway, corroborating and extending the findings observed in vitro. This evidence concerns the gene NAT10 and non-small cell lung carcinoma.